3422 g of sodium tetraphenylborate to 100 mL with water Dosage fo

3422 g of sodium tetraphenylborate to 100 mL with water.Dosage form of sulpirideDogmatil 50 capsules (Sanofil-Synthelbe SA, Spain), contained 50 mg sulpiride, lactose, methylcellulose, talc, magnesium stearate and other excipients to total capsule weight; Dogmatil solution (Sanofil-Synthelbe SA, Spain): 500 mg sulpiride, sodium cyclamate, hydroxyethylcellulose, methylparaben, propylparaben, citric, hydrochloric and sorbic acids, lemon essence and water to 100 mL. Guastil pedriatic suspension (Uriach, Spain): 500 mg sulpiride, sacharose, sodium saccharin, microcrystalline cellulose, sodium carmelose, sodium chloride, methyl p-hydroxybenzoate, propyl p-hydroxybenzoate, strawberry essence and water to 100 mL.2.2.

Ion-exchanger preparationThe sulpiride tetraphenylborate (SPD-TPB) ion exchanger was prepared by reacting 25 mL of 2 �� 10-2 M sulpiride hydrochloride solution with 50 mL 1 �� 10-2 M sodium tetraphenylborate solution. The mixture was filtered through a porous number 4 sintered glass crucibles. The residue was first washed with distilled water until no chloride ion was detected in the washing solution and then with hexane before being dried at room temperature.2.3. Construction and conditioning of the electrodeThe membranes were prepared by dissolving 3.0 or 9.0 mg of SPD-TPB, 100 mg PVC and 200 mg of the plasticizer (NPOE, DOS or DBP) in 3 mL of tetrahydrofuran. This solution was poured into a Fluka glass ring (inner diameter 28 mm, height 30 mm) on a Fluka glass plate, and allowed to evaporate overnight.

A 7 mm diameter piece was cut out with a Fluka punch for ion-selective membranes and incorporated into a Fluka electrode body ISE containing 1 �� 10-2 M potassium chloride and 1 �� 10-3 M sulpiride, and saturated with excess AgCl as internal filling solution. The composition of the different membranes assayed is shown in Table 1.Table 1.Composition of the membranes.The electrodes were conditioned by soaking with constant stirring in a solution containing 1 �� 10-3 M sulpiride in acetate/acetic buffer of pH 4.7 until the electrode provided a constant potential. When not in use, the electrode was kept immersed in the same solution.2.4. Measurement systemPotentials were measured with an Orion 960 Autochemistry System, the recorder output of which was connected to a personal computer, with acquisition program, via a DGH Corporation 1121 module analogue-to-digital converter (Manchester, UK).

An Orion 90-02 double junction silver-silver chloride reference electrode containing 10 % (w/w) solution of KNO3 in the outer compartment and a Fluka electrode body ISE, were used. Figure Dacomitinib 2 shows the measurement system used.Figure 2.Measurement system used. A: Sulpiride selective electrode; B: Stirrer; C: Reference electrode; D: Sample; E: Potentiometer; F: Analogue-to-digital converter; G: Personal computer.2.5.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>